As of 2025-07-03, the Relative Valuation of Intellipharmaceutics International Inc (IPCI.TO) is (0.07) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.08 CAD, the upside of Intellipharmaceutics International Inc based on Relative Valuation is -191.8%.
The range of the Relative Valuation is (0.03) - (0.12) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.3x - 1.0x | 0.6x |
| Forward P/E multiples | 0.3x - 1.0x | 0.6x |
| Fair Price | (0.03) - (0.12) | (0.07) |
| Upside | -136.7% - -247.0% | -191.8% |
| Date | P/E |